SCHEMBL24570858

SCHEMBL24570858

COC(=O)c1ccc2oc(CO[Si](C)(C)C(C)(C)C)cc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.48
TP53 P04637 2/20 0.45
POLB P06746 1/20 0.45
THRB P10828 1/20 0.45
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
IDO1 P14902 3/20 0.40
ALOX15 P16050 1/20 0.39
HTT P42858 1/20 0.39
MAPT P10636 3/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 3/20 0.38
CREBBP Q92793 1/20 0.38
CA12 O43570 1/20 0.38
CA2 P00918 1/20 0.38
CA3 P07451 1/20 0.38
CA6 P23280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30514557 1.00 HDAC6 (0.48) HDAC6TP53POLBTHRBHDAC3
SCHEMBL23616848 0.81 KDM4E (0.36) HDAC6TP53POLBTHRBALOX15
SCHEMBL5027947 0.80 F2 (0.56) HDAC6TP53POLBTHRBHDAC3
SCHEMBL28183709 0.80 HDAC6 (0.47) HDAC6TP53POLBTHRBHDAC3
SCHEMBL6489985 0.79 TP53 (0.47) HDAC6TP53POLBTHRBHDAC3
SCHEMBL6301115 0.79 TP53 (0.49) HDAC6TP53POLBTHRBHDAC3
SCHEMBL30514526 0.79 HDAC6 (0.52) HDAC6TP53POLBTHRBHDAC3
SCHEMBL24570865 0.79 HDAC6 (0.52) HDAC6TP53POLBTHRBHDAC3
SCHEMBL21438331 0.79 KDM4E (0.35) HDAC6POLBRAB9ASMN1; SMN2KDM4E
SCHEMBL5449158 0.79 PTPN11 (0.44) TP53POLBALOX15HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240083908-A1 TETRAHYDROTHIENOPYRIMIDINESULFONAMIDE COMPOUNDS ALIVEXIS, INC. (JP) 2024-03-14 US disclosed
EP-4269415-A1 TETRAHYDRO THIENOPYRIDINE SULFONAMIDE COMPOUND Modulus Discovery, Inc. (JP) 2023-11-01 EP disclosed
CN-116583286-A Tetrahydrothienopyrimidine sulfonamide compounds 某久拉斯株式会社 2023-08-11 CN disclosed
WO-2022138812-A1 TETRAHYDRO THIENOPYRIDINE SULFONAMIDE COMPOUND モジュラス株式会社 2022-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240083908-A1 TETRAHYDROTHIENOPYRIMIDINESULFONAMIDE COMPOUNDS TYMS, TYMP, TPMT HDAC6 3983/4885TP53 202/4885POLB 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.